RESUMEN

Controlling biofilms of bacteria is a challenging aspect because of their drug-resistance potentials against a range of antibiotics, demanding the development of active anti-biofilm agents. Rutin (R), a natural antioxidant, and benzamide (B), a synthetic antibacterial agent, have several pharmacological and antibacterial abilities. Herein, we developed PEG-PLGA NPs that synergistically carried rutin and benzamide as drug candidates, while displaying therapeutic and anti-biofilm  functions. These drug delivery NPs were synthesized by the oil-in-water emulsion (O/W) solvent evaporation technique. The obtained NPs were characterized by UV-vis, FT-IR, SEM, TEM, and DLS measurements. Confocal laser scanning microscopy was employed to evaluate the anti-biofilm capabilities against Staphylococcus aureus and Pseudomonas aeruginosa and further quantified the levels of residual biofilm constituents such as protein and exopolysaccharide (EPS). Drug release experiments showed the controlled release of rutin-benzamide (RB) for several days. Antibacterial analyses showed that the minimum inhibitory concentration (MIC) of NPs was at least two times lower than that of the free drugs. RB-PEG-PLGA NPs revealed that they targeted biofilm-forming bacteria through the disruption of the membrane and biofilm surface and were observed to be nontoxic when tested using human erythrocytes and human cell lines. In vivo evaluations in zebrafish showed that the NPs did not alter the antioxidant functions and histological features of tissues. On the basis of results obtained, it is substantiated that the rutin-benzamide-loaded nanocarrier offers potential anti-biofilm therapy due to its high anti-biofilm activity and biocompatibility.

RESUMEN

In recent days, 2-dimensional (2D) niobium disulfide (NbS2) with near-zero Gibbs free energy and superlative acid electrolyte stability has provoked a great deal of interest toward hydrogen evolution reaction (HER) electrocatalyst due to its active basal and edge sulfur sites. Herein, we developed a single step method for the direct deposition of 2D-NbS2 on high-aspect-ratio topographies of silicon nanowires (NWs) by chemical vapor deposition for the applications in HER electrocatalyst. The resultant 2D-NbS2 electrocatalyst demonstrates the HER overpotential of ∼74 mV vs RHE (reversible hydrogen electrode) @ 1 mA/cm2 under acidic conditions and stable for more than 20 h. More importantly, we developed the Si NWs array based photoelectrochemical water-splitting system with the direct deposition of 2D-NbS2 as HER catalyst. The resultant 2D-NbS2-Si NWs photocathode system demonstrates improved charge transfer characteristics at the Si-NbS2 interfaces that leads to an enhanced turn on potential (from 0.06 to 0.34 V vs RHE) with the current density of -28 mA/cm2 at the 0 V vs RHE. The results evidence the synergistic effect of 2D-NbS2 electrocatalysts that addresses poor surface kinetics of Si toward solar water electrolysis. Our comprehensive studies reveal NbS2 as a new class of photoelectrochemical cocatalyst for efficient solar HER performance by promoting the charge transfer process with prolonged acid stability.

RESUMEN

Conducting an efficient hydrogen evolution reaction (HER) using two-dimensional molybdenum disulphide as electrocatalysts remains a challenging task due to the insufficient active edge sites. In this regard, herein, molybdenum disulphide nanosheets with rich active sulphur sites were vertically grown on the graphene surface via a chemical vapour deposition process. The direct integration of vertically aligned MoS2 nanosheets on graphene forms a van der Waals (vdW) heterojunction, which facilitates a barrier-free charge transport towards the electrolyte as a result of unique and well-matched energy band alignment at the interface. The prospective combination of Ohmic graphene/MoS2 heterostructure and the high electrocatalytic edge activity of sulphur delivers an incredibly and small turn-on potential of 0.14 V vs. RHE in the acid electrolyte solution. Most importantly, the use of a vertical vdW device architecture exhibits nearly 8× improvement in HER than that of its layered counterpart. Moreover, the HER reaction is highly stable over 50 hours of continuous operation even after 150 days. The combined analysis of our study makes it certain that the graphene/MoS2 heterostructure will be an efficient alternative electrode for low-cost and large-scale electrochemical applications.

RESUMEN

In this article, we have examined the direct spectroscopic and microscopic evidence of efficient quantum dots-α-chymotrypsin (ChT) interaction. The intrinsic fluorescence of digestive enzyme is reduced in the presence of quantum dots through ground-state complex formation. Based on the fluorescence data, quenching rate constant, binding constant, and number of binding sites are calculated under optimized experimental conditions. Interestingly, fluorescence quenching method clearly illustrated the size dependent interaction of MPA-CdTe quantum dots. Conformational change of ChT was traced using synchronous fluorescence measurements, circular dichroism and FTIR spectroscopic methods. Furthermore, the AFM results revealed that the individual enzyme molecule dimensions were changed after interacting with quantum dot. Consequently, this result could be helpful for constructing safe and effective utilisation of QDs in biological applications.

Asunto(s)

Quimotripsina/química , Luz , Puntos Cuánticos , Quimotripsina/metabolismo , Dicroismo Circular , Espectrometría de Fluorescencia , Espectroscopía Infrarroja por Transformada de Fourier

RESUMEN

Theranostic nanoparticles with multifunctional ability have been emerging as a new platform for biomedical applications such as imaging, sensing and drug delivery. Despite gold nanorods (Au NRs) being an excellent nanosource with multifunctional versatility, they have certain limitations in biomedical applications, which include surfactant toxicity, biological stability and controlled drug release kinetics. Herein, we have developed Au NR-doxorubicin conjugates (DOX@PSS-Au NR) with improved drug loading efficiency (55 ± 6%) and minimum CTAB toxicity, by employing Au NRs (4.4 ± 0.5 aspect ratio) coated with poly(sodium 4-styrenesulfonate) (PSS). DOX@PSS-Au NR conjugates exhibited higher biological stability with sustained drug release kinetics at pH 5. The binding events of DOX molecules onto the PSS coated gold nanorods (PSS-Au NRs) were monitored through fluorescence quenching and the longitudinal surface plasmon resonance signals. Furthermore the anti-cancer potential and apoptosis inducing efficiency of DOX@PSS-Au NR conjugates in MCF-7 cells revealed higher therapeutic efficiency than free DOX, as corroborated through morphological assessment and in vitro cytotoxicity assay. In addition, DOX@PSS-Au NR conjugates showed efficient cellular entry and uniform intracellular distribution, suggesting the augmenting effect of chemotherapeutic drugs by Au NRs. Thus DOX@PSS-Au NR conjugates demonstrate significant therapeutic potential, suggesting their potential in anticancer therapy.